Drug maker Insmed (INSM) is rising 6% today after it released on Friday afternoon its estimate of the revenue generated by ...

Permanent changes such as bronchiectasis may persist. ABPA: Allergic bronchopulmonary aspergillosis; GINA: Global initiative for asthma. Adapted with permission from [7]. ABPA-S Fulfils the ...

Goldman Sachs has flagged Insmed Inc. as a potential merger candidate under the pro-business policies of the incoming Donald ...

inhaled multi-phage therapeutic for the treatment of chronic pulmonary Pseudomonas aeruginosa – P.a. or P. aeruginosa – infections in non-cystic fibrosis bronchiectasis, or NCFB, patients.

We recently compiled a list of the 10 Best Russell 2000 Stocks to Invest in According to Analysts. In this article, we are ...

Analyst Joseph Schwartz of Leerink Partners reiterated a Buy rating on Insmed (INSM – Research Report), with a price target of $85.00.Stay ...

Two pulmonologists were sued for malpractice but not held liable after failing to detect liver cancer in a patient being treated for cough.

Dr Zaheer Mangera shares insights into the lung cancer pathway and the benefits and challenges of early diagnosis and lung ...

Boots Superintendent Pharmacist Claire Nevinson says most coughs can usually be managed at home but there are times it is ...

The relationship between chronic obstructive pulmonary disease (COPD) and chronic bronchitis (CB) is important, significant and overlapping in nature. This review will analyze the relationship ...

"There is a dire need to provide an alternative treatment option to these patients." The marketing applications have been filed in the US and EU on the strength of the phase 3 TULIP trial ...

If you suddenly feel short of breath and a bit anxious, it might be something called "dyspnea." Let's dive into what the ...